Molecular Partners AG
MOLN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001745114
No open-market purchases or sales by Molecular Partners AG insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $13.8M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Molecular Partners AG changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 6 | 6 | 0 |
| Shares | 3.58M | 3.59M | +7.03K (+0.2%) |
| Value | $13.3M | $15.6M | +$2.27M (+17.1%) |
New holders (1)
Institutions that held Molecular Partners AG at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| SmartHarvest Portfolios, LLC | 12,311 | $53.7K | 0.02% |
Sold out (1)
Institutions that held Molecular Partners AG at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Bank of America Corp | 157 | $582 |